Eric Peterson has been named president of BioVentures LLC at the University of Arkansas for Medical Sciences of Little Rock. Peterson had held the position on an interim basis since March 2024. “Together, we will strive to bring groundbreaking discoveries to market, benefiting our institution, the state of Arkansas and beyond,” Peterson said in a press release.
Peterson has been with UAMS for more than a decade. He was previously executive vice president of BioVentures and also serves as an associate professor in the College of Medicine’s Department of Pharmacology & Toxicology. He is the chair of the UAMS Patent & Copyright Committee, a position he has held since February 2021. Peterson’s primary research focuses on the design of antibody nanotechnology and gene therapy technologies that could reduce or block the rewarding effects of methamphetamine use disorder. He is listed as an inventor on three patents for his contributions to immunotherapies for drug use disorder treatment.
Peterson received a bachelor of arts in biology from the University of Missouri and holds a doctorate in biology from the University of Arkansas at Fayetteville.
Sign up for Daily E-news
